Introgen and Clinical Collaborators to Report New Results with,Advanced-Stage Cancer Therapies at Upcoming Medical Meetings ( stem in Replicating Adenovirus Using a...)

HOME >> MEDICINE >> TECHNOLOGY

Introgen and Clinical Collaborators to Report New Results with,Advanced-Stage Cancer Therapies at Upcoming Medical Meetings

stem in Replicating Adenovirus Using a Permissive Immune Competent Syrian Hamster Model, William Wold, Ph.D., St. Louis University School of Medicine: Presentation on Thurs., May 31, from 9:30 - 11:30 a.m. at Washington State Convention Center during symposium titled "Cancer: Hot Topics in Cancer Gene Therapy"

-- MDA-7 (INGN-241) Kills Chemoresistant Cancer Cells and Restores Chemosensitivity to Cisplatin, Abstract #197: Presentation during "Cancer: Apoptosis and Suicide" poster session on Thurs., May 31, from 5:00 - 8:00 p.m. at Washington State Convention Center by Rajagopal Ramesh, Ph.D., M. D. Anderson Cancer Center

-- Effect of Pre-existing Anti-Adenovirus Immunity and Anti-Tumor Immunity on the Efficacy of Adenovirus Vectors in Immunocompetent Syrian Hamster Model, Abstract #668: Presentation during "Immune Responses to Adenoviral Vectors" poster session on Fri, June 1, from 5:15- 8:15 p.m. in Hall 4AB at Washington State Convention Center by Debanjan Dhar, St. Louis University School of Medicine

-- Anticancer Activity of Oncolytic Adenovirus Vector Armed with IFN-alpha and ADP is Enhanced by Pharmacologically-Controlled Expression of TRAIL, Abstract #588: Presentation during "Cancer Immunotherapy II" poster session on Fri., June 1, 2007 from 5:15 - 8:15 p.m. in Hall 4AB at Washington State Convention Center by Elena V. Shashkova, VirRx, Inc.

-- Clinical Experience with the mda-7/IL-24 Tumor Suppressor, Abstract # 380: Presentation during "Tumor Suppressor and Targeted Gene Therapy" poster session and oral presentation on Friday, June 1, 2007 at 8:45 a.m. at the Washington State Convention Center by Sunil Chada, Ph.D., Introgen Therapeutics, Inc.

About Introgen Therapeutics, Inc.

Introgen Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases. Introgen is developing molecular therapeutic
'"/>

Page: 1 2 3
Related medicine technology :

1. Introgen Reports Updated Phase 2 Advexin Data Correlating Improved Survival, Tumor Responses and Predictive p53 Biomarker
2. Introgen Reports Promising Phase 1/2 Clinical Results With INGN 241 in Patients With Advanced Solid Tumors
3. Introgens Advexin Demonstrates Clinical Benefit in Inherited Cancer
4. Preclinical Studies Identify Novel Approach for Enhancing the Anticancer Activity of Introgens INGN 241
5. Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference
6. Genetic Analysis Systems Enter the Clinical Mainstream
7. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
8. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
9. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
10. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
11. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society

Post Your Comments:

(Date:5/21/2013)... NEW YORK , May 21, 2013 ... market research report is available in its ... Global Markets and Technologies for Optical Coherence ... STUDY OBJECTIVES ... conducting this study is to offer synopsis ...

(Date:5/21/2013)... , May 21, 2013 Janssen R&D Ireland ... from the global Phase 3 PROMISE study demonstrating ... (TMC435) led to sustained virologic response 12 weeks ... percent of treatment-experienced genotype 1 chronic hepatitis C ... stages of liver fibrosis, when administered once daily ...

(Date:5/21/2013)... U.S. spending on specialty prescription drugs — ... cancer, multiple sclerosis and rheumatoid arthritis — is projected ... according to a forecast released today by Express Scripts ... "As we see what,s on the ... act so they can continue to offer an affordable ...

[0] Global Markets and Technologies for Optical Coherence Tomography (OCT)[0] Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients [0] U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015

... Systems Ltd. (Nasdaq: DHRM ) ("Dehaier" or ... marketing and sale of medical devices and homecare medical ... Weibing Yang as and Dr. Genhui Chen directors of ... fills the vacancy resulting from the resignation of Ms. ...

... Researchers have published the largest single patient population ... patients with retrievable inferior vena cava (IVC) filters—devices ... the lungs. This study, which is important for ... existing guidelines developed by the Society of Interventional ...

Cached Medicine Technology:Dehaier Medical Announces Changes to Board of Directors 2 Dehaier Medical Announces Changes to Board of Directors 3 IVC Filters: Society of Interventional Radiology Leads in Patient Care, Safety, Research 2 IVC Filters: Society of Interventional Radiology Leads in Patient Care, Safety, Research 3 IVC Filters: Society of Interventional Radiology Leads in Patient Care, Safety, Research 4

Dehaier Medical Announces Changes to Board of Directors IVC Filters: Society of Interventional Radiology Leads in Patient Care, Safety, Research

(Date:5/21/2013)... Boca Raton, Fla. (PRWEB) May 21, 2013 ... TV program distributed on cable networks and cable channels ... of new episodes on its YouTube channel. The producers ... profiles of companies in the shipping industry, the manufacturing ... program highlights pioneering medical facilities and medical practitioners in ...

(Date:5/21/2013)... Dallas, Texas (PRWEB) May 21, 2013 ... relationships. With the help of Texas Counseling’s Sexuality ... of communication, and the development of healthier habits ... group workshops available for both couples and individuals ... couples enhance their relationships and learn skills to ...

(Date:5/21/2013)... Brazilian funding agency for scientific and technological research So ... So Paulo, announced an investment estimated in US$ 680 ... (RIDCs) for a period of up to eleven years, ... 7. , Funding for the 17 RIDCs will ... faculty, technicians, support personnel, and infrastructure). Host institutions will ...

(Date:5/21/2013)... Go Classy Tours, the oldest and ... redesigned their website featuring N Resort in Jamaica ... bars and dining. The website, which has always featured ... guest reviews, will now have a broader range of ... on culinary local recipes, flora and fauna, featured pictures ...

(Date:5/21/2013)... va (PRWEB) May 21, 2013 ... critical technology and management consulting solutions to the ... of Business Development. In the newly created ... leading all aspects of the firm’s business development ... and proposal management functions, and leading strategies to ...

Breaking Medicine News(10 mins):Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2 Health News:Workshops Offered To Identify Underlying Challenges That Put Strain On Relationships 2 Health News:Research at the cutting edge of knowledge 2 Health News:The Oldest and Original Nudist Travel Agency for NResort Announced Today a Redesigned Website Featuring Information on Culinary Events, Flora and Fauna, and Photography 2 Health News:Octo Consulting Group Appoints Tracy Denny as Vice President of Business Development 2

[0] In View hosted by Larry King Announces New Videos on its YouTube Channel [0] Workshops Offered To Identify Underlying Challenges That Put Strain On Relationships [0] Research at the cutting edge of knowledge [0] The Oldest and Original Nudist Travel Agency for NResort Announced Today a Redesigned Website Featuring Information on Culinary Events, Flora and Fauna, and Photography [0] Octo Consulting Group Appoints Tracy Denny as Vice President of Business Development

... Wittenberg, MD, uses an,investor,s technology to yield the ... 6 When Scottsdale businessman,Warren Kaplan decided a ... had no,idea that an innovative medical product Possis ... gifted interventional radiologist - save his daughter,s life., ...

... Nov. 6 Repligen Corporation,(Nasdaq: RGEN ) ... Phase 2b,clinical trial to evaluate the use of ... bipolar depression. This Phase 2b study is a,multi-center, ... patients with bipolar depression will receive,either RG2417 or ...

... SALT LAKE CITY, Nov. 6 "In a remarkable ... history of cosmetics, women around the,country have been applying ... of fine lines, wrinkles and crows, feet." Five years ... a revolution in the cosmetic,industry: a little-known American stretch-mark ...

... 6 Performance Health Technologies,Inc. (PHT), a leader ... guide and monitor exercise and rehabilitation, announced,today that ... the September 5 edition of "60 Second Science," ... "Virtual Rehabilitation: Wireless Motion Sensor to Help,Treat That ...

... NEW YORK, Nov. 6 According to the ... The African,American community is one of the groups ... diagnosed. With November being National Diabetes Month,Black Expressions(R) ... that raise,awareness about diabetes and offer information about ...

... Salud to Use Pan-Enterprise Search Platform to,Identify ... and SAN FRANCISCO, November 6 /PRNewswire-FirstCall/,-- Autonomy ... global leader in,infrastructure software for the enterprise ... Spain,s most innovative health service,provider, has selected ...

Cached Medicine News:Health News:Innovative Deep Vein Thrombosis Treatment Yields Priceless Payoff 2 Health News:Innovative Deep Vein Thrombosis Treatment Yields Priceless Payoff 3 Health News:Repligen Initiates Phase 2b Clinical Trial of RG2417 in Bipolar Disorder 2 Health News:Repligen Initiates Phase 2b Clinical Trial of RG2417 in Bipolar Disorder 3 Health News:Repligen Initiates Phase 2b Clinical Trial of RG2417 in Bipolar Disorder 4 Health News:Happy Birthday, StriVectin! The Skin Cream that Revolutionized the Anti-Aging Market 2 Health News:Happy Birthday, StriVectin! The Skin Cream that Revolutionized the Anti-Aging Market 3 Health News:Performance Health Technologies Garners Additional Media Coverage, Including Scientific American's News Blog 2 Health News:Performance Health Technologies Garners Additional Media Coverage, Including Scientific American's News Blog 3 Health News:National Diabetes Month Book Suggestions From Black Expressions(R) Book Club 2 Health News:Leading Spanish Health Service Provider Selects Autonomy for Innovation in Healthcare 2 Health News:Leading Spanish Health Service Provider Selects Autonomy for Innovation in Healthcare 3 Health News:Leading Spanish Health Service Provider Selects Autonomy for Innovation in Healthcare 4

Innovative Deep Vein Thrombosis Treatment Yields Priceless Payoff Repligen Initiates Phase 2b Clinical Trial of RG2417 in Bipolar Disorder Happy Birthday, StriVectin! The Skin Cream that Revolutionized the Anti-Aging Market Performance Health Technologies Garners Additional Media Coverage, Including Scientific American's News Blog National Diabetes Month Book Suggestions From Black Expressions(R) Book Club Leading Spanish Health Service Provider Selects Autonomy for Innovation in Healthcare

... The Affinity pacemaker family ... smallest, truly automatic devices. ... combination of advanced technologies ... DR pacemaker incorporates the ...

... pacemaker family offers some ... automatic devices. Featuring the ... advanced technologies ever seen, ... incorporates the exclusive ventricular ...

... The Guidant INSIGNIA ... sophisticated patient-specific, easy-to-use features ... and enhanced patient safety. ... are programmed using the ...

... a small bench top chemistry analyzer that utilizes ... strips with results available within 8 - 15 ... The instrument accepts whole blood samples and is ... card. At the conclusion of testing, results are ...

Medicine Products:

Affinity™ VDR Pacemaker Affinity™ DR Pacemakers INSIGNIA Ultra SR SPOTCHEM™ EZ